PGE2 activates cementoclastogenesis by cementoblasts via EP4

Area of Science:

• Periodontology
• Molecular Biology
• Cell Biology

Background:

• Periodontitis causes tooth exfoliation through cementum and alveolar bone destruction.
• Prostaglandin E2 (PGE2) and its receptors (EPs) are known to influence osteoblast-mediated osteoclastogenesis.
• The role of PGE2 and EPs in cementoblast-mediated cementoclastogenesis remains uncharacterized.

Purpose of the Study:

• To investigate the role of the Prostaglandin E2 (PGE2)-EPs pathway in regulating cementoblast-mediated cementoclastogenesis.
• To determine if PGE2 signaling through specific EP subtypes affects the expression of key regulatory molecules in cementoblasts.

Main Methods:

• OCCM-30 cells (a mouse cementoblast cell line) were treated with PGE2 and specific EP agonists.
• Quantitative real-time PCR was used to assess mRNA levels of RANKL, IL-6, and OPG.
• Co-cultures of OCCM-30 cells with bone marrow cells were used to evaluate the induction of TRAP-positive cells (a marker for osteoclasts/cementoclasts).
• The effect of an EP4 antagonist was examined to confirm pathway specificity.

Main Results:

• PGE2 and an EP4 agonist significantly upregulated RANKL and IL-6 mRNA expression in OCCM-30 cells.
• PGE2 and the EP4 agonist downregulated Osteoprotegerin (OPG) mRNA expression.
• An EP4 antagonist blocked the effects of PGE2 on RANKL, IL-6, and OPG mRNA levels.
• PGE2 treatment induced TRAP-positive cells in co-cultures, indicating cementoclastogenesis, via the EP4 pathway.

Conclusions:

• The Prostaglandin E2 (PGE2)-EP4 pathway plays a crucial role in promoting cementoblast-mediated cementoclastogenesis.
• PGE2 signaling regulates the expression of RANKL and OPG in cementoblasts, thereby influencing cementoclast formation.
• These findings highlight a potential therapeutic target for managing periodontitis-associated cementum and bone loss.